Raymond James Reiterates Outperform Rating on Aquestive Therapeutics (AQST)
Go back to Raymond James Reiterates Outperform Rating on Aquestive Therapeutics (AQST)| (NASDAQ: AQST) | Delayed: 4.12 +0.18 (4.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.94 | 52 Week High | $ | |||
| Open | $3.89 | 52 Week Low | $ | |||
| Day High | $4.16 | P/E | N/A | |||
| Day Low | $3.81 | EPS | $ | |||
| Volume | 2,356,257 | |||||

